Back to Search
Start Over
Palatin Technologies initiates Phase 2 bremelanotide clinical study to treat obesity
- Source :
- M2 Pharma. June 13, 2024
- Publication Year :
- 2024
-
Abstract
- M2 PHARMA-June 13, 2024-Palatin Technologies initiates Phase 2 bremelanotide clinical study to treat obesity (C)2024 M2 COMMUNICATIONS Palatin Technologies, Inc. (NYSE American: PTN), a US-based biopharmaceutical company developing first-in-class medicines [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.797558787